David Hale Named New CEO of Ascom
Ascom Holding AG has made an exciting leadership change by appointing David Hale as the new CEO of the Ascom Group. With an impressive career spanning over two decades in technology and industry, Hale will officially join the company on February 4, 2026, succeeding Michael Reitermann, who has served as the interim CEO.
A Proven Executive with Diverse Experience
David Hale brings a wealth of international leadership experience to his new role, specifically within the medical device and pharmaceutical realms. Having served as the CEO of the Guerbet Group in France for five years, his robust background includes significant positions at General Electric (GE). During his tenure at GE, Hale played a crucial role in digital transformation initiatives, managing global product portfolios in both GE Healthcare Digital in the US and GE Healthcare Diagnostic Imaging in France. His dual citizenship in the US and France underscores his global perspective and adaptability.
Vision for the Future
Expressing his enthusiasm for the new role, David Hale stated, "I am honored to join Ascom as CEO and thank the Board of Directors for their trust. My goal is to collaborate with the exceptional teams at Ascom to create impactful solutions that bring data to life every day. Starting my career at Ascom in Bern in 1991 makes this opportunity particularly meaningful, as it brings my journey full circle." This personal narrative highlights Hale's connection to the company and his eagerness to contribute to its future.
Acknowledging Past Leadership
The Board of Directors at Ascom extended their heartfelt gratitude to Michael Reitermann for his service as interim CEO. His leadership and dedication during a transitional phase have been invaluable. Michael will continue his journey with the company as a member of the Board, ensuring a smooth transition and continuity in leadership.
About Ascom
Ascom is a global solutions provider that focuses on communication and workflow solutions designed for various industries, including healthcare. By leveraging cutting-edge technology, Ascom aims to enhance operational efficiency and improve patient outcomes. Under Hale's new leadership, Ascom is poised to advance its strategic objectives and deliver innovative solutions that meet the evolving needs of its clients.
Strategic Priorities Ahead
As Ascom moves forward, the company plans to emphasize innovation and excellence in service delivery. With David Hale at the helm, stakeholders can expect a clear focus on advancing the company’s strategic goals. His extensive experience positions him to address challenges and capitalize on new opportunities in a rapidly changing market landscape.
Frequently Asked Questions
Who is the new CEO of Ascom?
David Hale has been appointed as the new CEO of Ascom Holding AG.
What is David Hale's professional background?
David Hale has over 25 years of leadership experience in the medical device and pharmaceutical industries.
When will David Hale officially start his role as CEO?
He will officially join Ascom on February 4, 2026.
Who did David Hale succeed as CEO?
He succeeded Michael Reitermann, who served as interim CEO prior to Hale's appointment.
What are Ascom's plans under David Hale's leadership?
Ascom aims to focus on innovation and enhancing service delivery in the healthcare sector with Hale's leadership.
